Efficacy Is Maintained With Long-term Intermittent Use of Ubrogepant for the Acute Treatment of Migraine (111)
Acute migraine
DOI:
10.1212/wnl.94.15_supplement.111
Publication Date:
2023-12-07T05:28:50Z
AUTHORS (10)
ABSTRACT
Monday, April 27April 14, 2020Free AccessEfficacy Is Maintained With Long-term Intermittent Use of Ubrogepant for the Acute Treatment Migraine (111)Joel M. Trugman, Jessica Ailani, Susan Hutchinson, Kerry Knievel, Kaifeng Lu, Sung Yun Yu, Michelle Finnegan, Lawrence Severt, Armin Szegedi, and Richard B. LiptonAuthors Info & AffiliationsApril 2020 issue94 (15_supplement)https://doi.org/10.1212/WNL.94.15_supplement.111 Letters to Editor
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....